MGTX logo

MeiraGTx Holdings
MGTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$639.90M
EV
$713.12M
Shares Outstanding
80.49M
Beta
1.39
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
8
P/E 2025E
7.41x
P/Revenue 2025E
60.21x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
-
Net Profit Margin 2025E
-1510.07%
ROE 2025E
-183.12%
ROCE 2024
-143.48%

Dividends

DPS 2025E
$0.00
Payout Ratio 2025E
0.00%
Div. Yield 2025E
0.00%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About MeiraGTx Holdings plc

gainify
MGTX logo

MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular dis...

Sector

Healthcare

Industry

Biotechnology

CEO

Forbes, Alexandria

Employees

409

IPO Date

2018-06-08

Headquarters

655 Third Avenue, Suite 1115, New York, New York, 10017, United States

📊 Stock Price & Performance

The last closing price of MeiraGTx Holdings (MGTX) is $7.95, reflecting a +1.02% change from the prior session. Last updated: December 31, 2025 at 4:03 PM Eastern Time

Review the recent MGTX stock performance trends:Past 1 Month: MeiraGTx Holdings (MGTX) shares have -4.22%.Past 3 Months: The stock has -3.40%.Past 6 Months: MGTX shares have +21.93%. Last updated: December 31, 2025 at 11:29 PM Eastern Time

Over the last year, MeiraGTx Holdings (MGTX) has established a 52-week price range between a high of $9.73 and a low of $4.55. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:29 PM Eastern Time

MeiraGTx Holdings (MGTX) is considered a medium volatility stock. It has a beta of 1.39, which means it typically moves 1.39 times as much as the broader market. Over the past 52 weeks, MGTX has traded within a $4.55 – $9.73 range. Last updated: December 31, 2025 at 11:29 PM Eastern Time

Based on current MGTX analyst forecasts and market assumptions, the consensus price target for MeiraGTx Holdings (MGTX) is $26.88 for 2027. Relative to the current price of $7.95, this implies a positive upside of +238.05%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: December 31, 2025 at 11:29 PM Eastern Time

A $1,000 investment in MeiraGTx Holdings 5 years ago, when the stock was trading around $15.14, would be worth approximately $525.04 today, based solely on share price performance (excluding dividends). This represents a total return of -47.50% over the period, equivalent to a compound annual growth rate (CAGR) of -12.09%. Past performance reflects historical price movements only and does not imply future results. Last updated: December 31, 2025 at 11:29 PM Eastern Time

💰 Financial Metrics & Reports

The current MeiraGTx Holdings (MGTX) market capitalization is approximately $639.90M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, MeiraGTx Holdings's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:29 PM Eastern Time

In the most recently reported quarter, MeiraGTx Holdings (MGTX) generated $410.00K in revenue, representing a -96.24% year over year change. For the next quarter, analyst consensus currently expects revenue of approximately $3.94M, implying an expected -81.58% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: December 31, 2025 at 7:16 PM Eastern Time

In the most recently reported fiscal year, MeiraGTx Holdings (MGTX) generated net income of $-0.15B, compared with $-84.03M in the prior fiscal year, representing a -75.89% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of $-0.16B. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: December 31, 2025 at 7:16 PM Eastern Time

According to its latest quarterly filing, MeiraGTx Holdings (MGTX) reported EBITDA of $-42.90M, representing a -16.62% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: December 31, 2025 at 7:16 PM Eastern Time

Based on the latest available data, MeiraGTx Holdings (MGTX) is currently trading at a last twelve months (LTM) P/E ratio of -3.77x. Looking forward, the stock trades at a next twelve months (NTM) P/E ratio of -4.47x, based on consensus earnings estimates. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: December 31, 2025 at 7:16 PM Eastern Time

📅 Earnings & Dividends

MeiraGTx Holdings (MGTX) is currently scheduled to report its next earnings results on March 11, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: December 31, 2025 at 11:29 PM Eastern Time

In the most recently reported quarter, MeiraGTx Holdings (MGTX) revenue was $410.00K, compared with analyst consensus expectations of $6.97M, representing a -94.11% revenue surprise versus expectations. Earnings per share (EPS) for the quarter were $-0.62, compared with consensus estimates of $-0.49, resulting in an -26.53% EPS surprise. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: December 31, 2025 at 7:16 PM Eastern Time

MeiraGTx Holdings's (MGTX) earnings reports, including quarterly and annual financial statements, are available through the company's official regulatory filings with the U.S. Securities and Exchange Commission (SEC). On Gainify, you can access MeiraGTx Holdings's full set of filings, including earnings releases, Form 10-Q, Form 10-K, and other disclosures, in one place: MeiraGTx Holdings SEC Filings These filings provide detailed information on MeiraGTx Holdings's financial performance and are considered the primary source of verified financial data for publicly traded companies.

MeiraGTx Holdings (MGTX) does not currently pay a dividend. Over the last twelve months (LTM), the company paid $0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: December 31, 2025 at 7:16 PM Eastern Time

📈 Analyst Information

Analyst assessments of whether MeiraGTx Holdings (MGTX) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: $7.95Consensus price target: $26.88Implied return: +238.05% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: December 31, 2025 at 7:16 PM Eastern Time

Based on the latest available analyst coverage, MeiraGTx Holdings (MGTX) currently carries a Buy consensus rating. Analysts' average MGTX price target is $26.88. Relative to the current share price of $7.95, this suggests a potential price change of approximately +238.05%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: December 31, 2025 at 7:16 PM Eastern Time

Like other publicly traded stocks, MeiraGTx Holdings (MGTX) shares are bought and sold on stock exchanges such as Nasdaq and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for MeiraGTx Holdings (MGTX) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add MGTX to your watchlist.

MeiraGTx Holdings trades under the ticker symbol MGTX on the Nasdaq stock exchange. The ticker MGTX is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, MeiraGTx Holdings (MGTX) employs approximately 409 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: December 31, 2025 at 11:29 PM Eastern Time

MeiraGTx Holdings (MGTX) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest MeiraGTx Holdings (MGTX) stock peers based on overlapping products, services, and competitive dynamics:Zentalis Pharmaceuticals (ZNTL)Metagenomi (MGX)Foghorn Therapeutics (FHTX)Voyager Therapeutics (VYGR)Viridian Therapeutics (VRDN)C4 Therapeutics (CCCC)Mersana Therapeutics (MRSN)Forte Biosciences (FBRX) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to MeiraGTx Holdings.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.